A New study finds that a lack of essential medicine in the public sector drives patients to pay higher prices in the private sector.
The study analysed medicine availability from 45 surveys in 36 countries in The WHO geographical region. The figures were adjusted to account for differences in buying power of the local currency, and then compared to international reference prices.
They found a 38% average availability in the public sector.
Private sector mark up was high
Wholesale: 2% – 380%
Retail: 10% – 552%